• Comparative Efficacy and Safety of Empagliflozin with Other Anti-Diabetic Drugs for the Treatment of Patients with Type 2 Diabetes Mellitus Who are Failing Insulin

    Nov 1, 2014, 00:00

  • Management of Crises and Risks in German Hospitals - Factors Influencing Medication Errors

    Nov 1, 2014, 00:00

  • Disutility Associated With Erectile Dysfunction in the Middle-Aged Or Older Males

    Nov 1, 2014, 00:00

  • Adjusting for Treatment Crossover in A Trametinib Metastatic Melanoma Rct- Identifying the Appropriate Method

    Nov 1, 2014, 00:00

  • Comparison of a Markov Cohort Model and a Discrete-Event Simulation for Economic Analyses of Treatments for Multiple Sclerosis

    Nov 1, 2014, 00:00

  • Knowledge on Medication Taking Behaviour, Balanced Diet and Physical Activity - A Survey Among the Adolescents

    Nov 1, 2014, 00:00

  • Integration of Cost–Effectiveness Assessment in the Market Access Scheme of Drugs and Medical Devices In France

    Nov 1, 2014, 00:00

  • Quality of Life in Hospitalized Seniors with Psychiatric Disorders

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of Biosimilar Infliximab For The Treatment Of Crohn's Disease In Six Central Eastern European Countries

    Nov 1, 2014, 00:00

  • Current Management and Barriers to Treatment for Wet Age-Related Macular Degeneration (Wamd)- Perspectives From Patients and Caregivers

    Nov 1, 2014, 00:00

  • The Cost of Blindness in the Republic of Ireland 2010-2020

    Nov 1, 2014, 00:00

  • Awarness and Prevention of Chronic Diseases in Japan

    Nov 1, 2014, 00:00

  • Benefit Of Positive Airway Pressure (Pap) Therapy In Sleep Apnoea (Sa) Patients With Type Ii Diabetes Mellitus (T2dm) In Germany- A Retrospective Comparative Cohort Analysis Based On A Statutory Health Insurance Database

    Nov 1, 2014, 00:00

  • Cost-Benefit-Analysis of a Targeted Hospital Wide Pcr-Based Admission Screening for Mrsa in a German University Hospital – Consideration of a Six-Year Time Period

    Nov 1, 2014, 00:00

  • The Research of Effects of Iguratimod(T-614) on the Apoptosis of Peripheral Blood Mononuclear Cell and TH1 in Rheumatoid Arthritis

    Nov 1, 2014, 00:00

  • Health Related Quality of Life And Health Care Utilization in Primary Care Patients With Moderate/Persistent Severity Asthma

    Nov 1, 2014, 00:00

  • Simulation of An Additional Go/No-Go Efficacy Interim Analysis in A Head-To-Head Rct

    Nov 1, 2014, 00:00

  • The Differences Between Cancer Drug Approvals in Japan and the USA

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Ranibizumab on Patients With Diffuse Diabetic Macular Edema Within the Public Mexican Health Care System

    Nov 1, 2014, 00:00

  • Study On Drug Utilization And Assessment Of Stroke Risk Using Chads2 And Cha2ds2-Vasc Scoring In Elderly Patients With Non-Valvular Atrial Fibrillation

    Nov 1, 2014, 00:00

  • Impact of Caregiving for Patients with Alzheimer's Disease and Dementia on Psychiatric and Clinical Comorbidities in Brazil

    Nov 1, 2014, 00:00

  • Influenza Vaccination In Japan Among The General Population And High-Risk Groups

    Nov 1, 2014, 00:00

  • Assessment Of Diabetes Knowledge In Healthy Population Of Quetta City, Pakistan

    Nov 1, 2014, 00:00

  • Economic Burden in Direct Costs of Chronic Obstructive Pulmonary Disease (COPD) in Russia

    Nov 1, 2014, 00:00

  • A Database Study to Investigate the Incidence of Anaphylaxis and the Prescription Rate of Self-Injection Epinephrine in Japan

    Nov 1, 2014, 00:00

  • Progression of Physiological Parameters Over Time in Type 1 Diabetes Mellitus Patients in France

    Nov 1, 2014, 00:00

  • Economic Evaluation of Lanreotide Autogel in the Management of Acromegaly in Greece

    Nov 1, 2014, 00:00

  • Determinants of Health Care Utilization in Hypertensive Patients- A Longitudinal Analysis

    Nov 1, 2014, 00:00

  • Long-Term Work Productivity Costs Among Subjects With Early Rheumatoid Arthritis - A Nationwide Analysis Based on 7,831 Subjects' Sickness Absence Days and Income

    Nov 1, 2014, 00:00

  • Which Adverse Effects Influence the Dropout Rate in Selective Serotonin Reuptake Inhibitor (Ssri) Treatment?

    Nov 1, 2014, 00:00

  • Effectiveness of Hand Hygiene Promotion in Relation to Level of Investment- A Systematic Review

    Nov 1, 2014, 00:00

  • Romiplostim Cost Per Response In Itp Treatment In the Brazilian Health Care System

    Nov 1, 2014, 00:00

  • Trends In Clinical Drug Development Timeframes, 1981-2013 – An Example From Virology

    Nov 1, 2014, 00:00

  • The Potential Societal Cost Benefits of Improved Inhalation Technique With Duoresp® Spiromax® (Budesonide + Formoterol Fumarate Dihydrate) Compared With Symbicort® Turbuhaler® for the Management of Asthma and Chronic Obstructive Pulmonary D ...

    Nov 1, 2014, 00:00

  • The Pan-Genotypic Costs-Effectiveness Of Sofosbuvir in Hepatitis C Virus

    Nov 1, 2014, 00:00

  • Evaluating The Gap Between Physicians' And Patients' Understanding Of Patient Needs

    Nov 1, 2014, 00:00

  • An Analysis of the 2014 Moroccan Drug Price Cuts

    Nov 1, 2014, 00:00

  • Trends In Early Engagement Between Industry And HTA- Analysis of Scientific Advice Service Provided By Nice Since 2009

    Nov 1, 2014, 00:00

  • Economic Modeling of The Use of Botulinum Toxin A in A Homogenous Patient Population Based on Real-Life Clinical Practi Ulis-Ii (The Upper Limb International Spasticity Study)

    Nov 1, 2014, 00:00

  • Cic Users' Preference For Catheters Reducing The Uti Frequency

    Nov 1, 2014, 00:00

  • The Use Of Minimally Invasive Surgery (Mis) And Intraoperative Imaging Modalities In The Treatment Of Intracerebral Hemorrhage (Ich)- A Systematic Review Of The Literature

    Nov 1, 2014, 00:00

  • Satisfaction of Hiv Patients with Pharmacy Services in South Eastern Nigerian Hospitals

    Nov 1, 2014, 00:00

  • Management of Ischaemic Stroke Patients Enrolled in the Japan Stroke Databank (JSD)

    Nov 1, 2014, 00:00

  • A Retrospective Cohort Study of Risk Factors for Death Among Humman Immunodeficiency Virus Infected Adult Patients

    Nov 1, 2014, 00:00

  • Pharmaceutical Developpement- Africa an Emergent Market

    Nov 1, 2014, 00:00

  • Costs and Effectiveness of the Mediguide Technology in the Conditions of the Czech Republic

    Nov 1, 2014, 00:00

  • Patient Preferences in Treatment of Diabetes Mellitus- A Systematic Review of Stated Preference Surveys

    Nov 1, 2014, 00:00

  • Assessing Balance in Baseline Characteristics Using Different Propensity Adjusted Methods for Bipolar I Mixed Disorder Patients Initiating Asenapine Versus Other Oral Atypical Antipsychotics

    Nov 1, 2014, 00:00

  • Why Are There Differences In Hta Recommendations Across Countries? A Systematic Comparison of Hta Decision Processes for A Sample of Orphan Drugs In Four Countries

    Nov 1, 2014, 00:00

  • Measuring Change in Quality of Life- Can We Distinguish Recall Bias and Scale Recalibration?

    Nov 1, 2014, 00:00

  • Pay-For-Performan Balancing Cost and Care

    Nov 1, 2014, 00:00

  • Comparison of Health Care Resource use and Costs in Patients with Opioid Prescription Drug Dependence (Opd) Treated with Buprenorphine/Naloxone and Patients without Pharmacological Treatment- Retrospective Analysis of us Public Insurance Cl ...

    Nov 1, 2014, 00:00

  • Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infections (CDI) also Known as Clostridium Difficile-Associated Diarrhoea (CDAD) in Spain

    Nov 1, 2014, 00:00

  • Knowledge and Perception of Medical and Pharmacy Students Toward The Usage of Sunblock

    Nov 1, 2014, 00:00

  • Budget Impact of Orphan Drugs In the Netherlands In The Period 2006-2012

    Nov 1, 2014, 00:00

  • Cost-Minimization Analysis of Bevacizumab Verse Cetuximab in First-Line Treatment for Metastatic Colorectal Cancer in Kras Wild-Type Patients in the Supplementary Health Care System in Brazil

    Nov 1, 2014, 00:00

  • Cost of Best Supportive Care for Non-Small Cell Lung Cancer Patients – A German Perspective

    Nov 1, 2014, 00:00

  • Comparison of the Economic Burden and Health care Utilizations of u. S. Veteran Patients Diagnosed with Type 2 Diabetes Mellitus

    Nov 1, 2014, 00:00

  • Markov Model-Based Economic Evaluation of Combination Therapy with Ezetimibe and Statin Monotherapy

    Nov 1, 2014, 00:00

  • Impact of Generic Substitution On the Prescribing of Meprobamate-Containing Combination Analgesics In South Africa

    Nov 1, 2014, 00:00

  • Recombinant Growth Hormone Therapy in Children with GH Deficiency- First Interventional Study in Armenia

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Theintroduction of A National Adherence Program for Type 2 Diabetes In Hungary

    Nov 1, 2014, 00:00

  • Shared Decision-Making in Women with Early Stage Breast Cancer and Implications for Long-Term Health-Related Quality of Life

    Nov 1, 2014, 00:00

  • A Cost-Effectiveness Analysis Of Onabotulinumtoxina Verse. Best Supportive Care (bsc) For The Treatment Of Anticholinergic Treatment-Refractory Neurogenic Detrusor Overactivity (ndo)

    Nov 1, 2014, 00:00

  • Developing a Drug Price Reference Index in the Philippines

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation

    Nov 1, 2014, 00:00

  • Impacts of Lower Back Pain- Refinement of the Pain Assessment for Lower Back-Impacts Questionnaire (Pal-I) Using a Mixed Methods Approach

    Nov 1, 2014, 00:00

  • The Effect of Degressive Financing Method on the Hungarian Drg Based Hospital Reimbursement Between 2011-2013

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of the Therapy of Endometriosis

    Nov 1, 2014, 00:00

  • The Impact of Drug Policy on the Utilization of Medicines for Treatment of Cardiovascular Diseases in Slovak Republic

    Nov 1, 2014, 00:00

  • Comparative Effectiveness of Biological Agents With Diseases Modifying Anti-Rheumatic Drugs For Methotrexate Failure Rheumatoid Arthritis Patients- A Baysian Mixed Treatment Comparison

    Nov 1, 2014, 00:00

  • Annual Cost Of Conservative Treatment Of Supraventricular Tachycardias In Poland

    Nov 1, 2014, 00:00

  • The Effectiveness of First Trimester Combined Screening on Reducing the Rate of Invasive Genetic Procedures in a City Based Population of Hungary 2010-2013

    Nov 1, 2014, 00:00

  • Components of Sustainable Health Systems- What Is Known About The Cost-Effectiveness of Clinical Care?

    Nov 1, 2014, 00:00

  • Economic Burden of Febrile Neutropenia in Solid Tumor and Lymphoma Patients- An Observational Study in Singapore

    Nov 1, 2014, 00:00

  • Hta Studies On Orphan Drugs By Rebratsxmembers

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Exenatide Bid Versus Insulin Lispro Tid As Add-On Therapy to Titrated Insulin Glargine in Patients With Type 2 Diabetes – An Analysis From The Swedish Health Care Perspective

    Nov 1, 2014, 00:00

  • Incidence and Risk of Cardiotoxicity Induced by Sunitinib in Patients with Renal Cell Carcinoma- A Population-Based Case-Control Study in Chinese Population

    Nov 1, 2014, 00:00

  • PROF DR Hasbullah Thabrany

    Nov 1, 2014, 00:00

  • From Regulatory Approval to Subsidised Patient Access in the Asia-Pacific Region- A Comparison of Systems Across Australia, China, Japan, Korea, New Zealand, Taiwan And Thailand

    Nov 1, 2014, 00:00

  • Prevalence of Severe Treatment Resistant Hypertension and Eligibility for Catheter-Based Renal Denervation in Australia – a Preliminary Analysis

    Nov 1, 2014, 00:00

  • Comparison of Clinical Characteristics of Patients With Rheumatoid Arthritis (Ra) Receiving Biologic Monotherapy and Biologic-Containing Combination Therapy in Europe

    Nov 1, 2014, 00:00

  • Impact Of Pharmacoeconomic Guidelines on the Reimbursement Process of Medicines In Serbia In 2014

    Nov 1, 2014, 00:00

  • HTA Approach in Italy. Structure, Methods, And Process Of Veneto Region's Evaluation Of Pharmaceutical Effectiveness Unit (Unità Di Valutazione Dell'efficacia Del Farmaco, Uvef)

    Nov 1, 2014, 00:00

  • Multiple Decision Criteria for Assessing An Incremental Cost-Effectiveness Ratio of Expensive Health Technologies

    Nov 1, 2014, 00:00

  • Questionnaire Analysis on Pharmacists Role and Drug Reimbursement List Adjustment Mechanism Under the Current China Health Insurance System

    Nov 1, 2014, 00:00

  • Experiences With Price Competition of Biosimilar Drugs in Hungary

    Nov 1, 2014, 00:00

  • Economic Evaluation Of Percent Free Psa For Prostate Cancer Detection In Taiwanese Men

    Nov 1, 2014, 00:00

  • Psychometric Evaluation of the Hypoglycaemia Perspectives Questionnaire in Patients With Type 2 Diabetes Mellitus

    Nov 1, 2014, 00:00

  • Budget Impact Analysis of Introducing Biosimilar Infliximab for the Treatment of Auto Immune Disorders In Five European Countries

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Aprepitant in Egyptian Patients Receiving Highly Emetogenic Therapy from the Third Party Payer Perspective

    Nov 1, 2014, 00:00

  • Examining the Economic Benefits of Lifestyle Intervention in Segments of A Prediabetic Population

    Nov 1, 2014, 00:00

  • Frequency of Outpatient Physiotherapy Services in Neurology Diseases in Hungary

    Nov 1, 2014, 00:00

  • Applicability of Turkish Pricing Policy on Price Increases

    Nov 1, 2014, 00:00

  • Budget Impect Analysis

    Nov 1, 2014, 00:00

  • Clinical Pathway And Health Care Resources Utilization Of A Patients Cohort At High Risk Of Cardiovascular Disease Of Local Health Care Unit (Asln°1) Of Milan- A Results Of Intervention On Secondary Prevention

    Nov 1, 2014, 00:00

  • Inclusion and Consideration of Patient Preferences in Amnog Early Benefit Assessments

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of Dabigatran Compared With Warfarin, Apixaban, Rivaroxaban And Low Molecular Weight Heparins For The Treatment And Secondary Prevention Of Venous Thromboembolism In Colombia

    Nov 1, 2014, 00:00

  • Patterns and Predictors of Hospital Readmission in Taiwan

    Nov 1, 2014, 00:00

  • Effects and Safety of Ceftriaxone Versus Levofloxacin in Treating Community-Acquired Pneumonia- A Sysytematic Review

    Nov 1, 2014, 00:00

  • Sensitivity Of The Safuca Questionnaire To Detect Differences Between Atrial Fibrillation Patients Treated With Vitamin-K Antagonist Against Those Treated With New Oral Anticoagulants

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Empagliflozin (Jardiance®) 10 Mg And 25 Mg Administered As An Add-On To Metformin And Sulfonilurea (Met+Su) Compared To Other Sodium-Glucose Co-Transporter 2 Inhibitors (Sglt2is) in Patients with Type 2 Diabetes Mellit ...

    Nov 1, 2014, 00:00

  • Differential Item Functioning and the Eq-5d- Evidence From the Uk Hospital Episode Statistics

    Nov 1, 2014, 00:00

  • How Likely Warfarin Pharmacogenetic Test to be Cost-Effective in Thailand- A Threshold Analysis

    Nov 1, 2014, 00:00

  • Lubiprostone In Chronic Idiopathic Constipation- A Cost-Effectiveness Analysis

    Nov 1, 2014, 00:00

  • Joint Modelling Of The Change In Tumor Size And Overall Survival; A Parametric Model Considering Patient Heterogeneity Not Observed At Baseline

    Nov 1, 2014, 00:00

  • Hospital Cost of Thromboembolic Events in Breast or Prostate Cancer Patients

    Nov 1, 2014, 00:00

  • Drug Utilization Review of Acid Suppressants (Durable) – an Audit to Assess the Utilization of Proton Pump Inhibitors and Histamine H2-Receptor Antagonists in Canadian Hospitals

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis of Recommended Ranibizumab Regimen for Age-Related Macular Degeneration in China

    Nov 1, 2014, 00:00

  • Drug Survival Rates And Cost of Biological Agents for the Treatment of Moderate to Severe Psoriasis in the Balearic Islands (Spain)

    Nov 1, 2014, 00:00

  • Health Related Quality of Life (Hrqol) in Multiple Myeloma Patients Treated in a Tertiary Referral Hospital

    Nov 1, 2014, 00:00

  • Budget Impact Analysis of a Return-To-Work Intervention for Cancer Patients Shows Hospitals Bear the Costs, for Society to Enjoy the Benefits

    Nov 1, 2014, 00:00

  • Attitude Assessment of the Human Papilloma Virus (Hpv) in Hungary

    Nov 1, 2014, 00:00

  • Trends and Key Decision Drivers For Rejecting An Orphan Drug Submission Across Five Different HTA Agencies

    Nov 1, 2014, 00:00

  • Modelling Evolving Cancer Risk During Epidemiological Transition Using Economic Data

    Nov 1, 2014, 00:00

  • Comparison of Disease Status And Outcomes of Patients With Rheumatoid Arthritis (Ra) Receiving Adalimumab or Etanercept Monotherapy In Europe

    Nov 1, 2014, 00:00

  • A Pilot Study of the Effectiveness of Treatment Patients With Hemophilia In Ukraine

    Nov 1, 2014, 00:00

  • Budget Impact Analysis of Fingolimod in Relapsing Remitting Multiple Sclerosis

    Nov 1, 2014, 00:00

  • Mapping the Functional Assessment of Cancer Therapy – Breast (Fact-B) to the 5-Level Euroqol Group's 5-Dimention Questionnnaire (Eq-5d) Index in a Multi-Ethnic Asian Breast Cancer Patients

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Study of Botulinium Toxin Type a in Treatment of Post-Stroke Spasticity in the Russian Federation- Cost-Effectiveness Analysis

    Nov 1, 2014, 00:00

  • Evaluation of Medicine Prescription Pattern Using World Health Organization Prescribing Indicators in Iran- A Cross-Sectional Study

    Nov 1, 2014, 00:00

  • Occurrence, Survival And Annual Cost of Colorectal-, Breast-, Prostate- and Lung Cancer in Hungary

    Nov 1, 2014, 00:00

  • Comparison in Methods Between National Institute for Health And Care Excellence (Nice) Submissions For Sodium-Glucose Co-Transporter 2 Inhibitors (Sglt-2i)

    Nov 1, 2014, 00:00

  • Pricing Additional Benefit in Germany

    Nov 1, 2014, 00:00

  • Cost Per Response Analysis for Thrombopoietin Receptor Agonists (Tpo-Ras), In the Treatment of Adult Chronic Immune Thrombocytopenia (Itp) In Mexico

    Nov 1, 2014, 00:00

  • Factors Associated with Relocating to Nursing Homes Among Community-Dwelling Older Persons with Dementia

    Nov 1, 2014, 00:00

  • Association of Changes In Body Weight With Health Care Costs Among Patients With Newly-Diagnosed Type-2 Diabetes In Sweden

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Romiplostim for the Treatment of Chronic Immune Thrombocytopenia In Portugal

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Biologic Dmards in Patients With Severe or Mild-To-Severe Rheumatoid Arthritis After Conventional Dmards

    Nov 1, 2014, 00:00

  • Economic Evaluation Of Insulin Analogs Versus Human Insulin For Diabetes- A Systematic Review

    Nov 1, 2014, 00:00

  • Productivity Loss and Resource Utilization in Individuals Providing Care for Adults with Schizophrenia in the 5eu

    Nov 1, 2014, 00:00

  • Development Of A Collaborative European Pharmacoepidemiologic Post-Authorization Safety Study (Pass) Programme Examining Rivaroxaban Use In Routine Clinical Practice

    Nov 1, 2014, 00:00

  • Cost and Resource Use of Managing Major Depressive Disorder (MDD) in China

    Nov 1, 2014, 00:00

  • Decision Drivers For Brazil- An Analysis of Conitec Recommendations

    Nov 1, 2014, 00:00

  • Persistence to Treatment of Chronic Hepatitis B Virus (Hbv) Infection- A Study Based on the French Ims Lifelink Treatment Dynamics (LTD) Database

    Nov 1, 2014, 00:00

  • Study on Clinical and Immunological Outcomes of Antiretroviral Therapy in Hiv Positive Adult Patients in a Community Care Hospital

    Nov 1, 2014, 00:00

  • Adherence Rates For Peginterferon + Ribavirin Compared With Telaprevir + Peginterferon + Ribavirin In Medicaid And Commercial Patients Treated For Chronic Hepatitis C

    Nov 1, 2014, 00:00

  • CANCER TREATMENT IN CHINA- HOW ARE POLICY AND PRACTICE IN TIER 1 VERSUS TIER 2/3 CITIES IMPACTING PATIENT ACCESS TO HIGH-COST THERAPIES

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Screening Syphilis Among Pregnant Women

    Nov 1, 2014, 00:00

  • Retrospective Chart Review Studies- Strategies To Ensure Robust Data Quality

    Nov 1, 2014, 00:00

  • Recent Regulatory Reforms to Ensure Patient Safety in Clinical Research In India

    Nov 1, 2014, 00:00

  • Implementation of A Collaborative Pharmacy Practice Model in Nursing Homes of A Swiss Canton- Drug Cost Monitoring Between 2009 and 2012

    Nov 1, 2014, 00:00

  • The Effects of Reforms, Price Cuts And Global Budget Implementation on Original/Generic Medicine Sales Which Have Annual Average Highest Amount Of Sales Between 2008-2013 In Turkey

    Nov 1, 2014, 00:00

  • Clinical Trial-Based Cost-Effectiveness Analysis of Indacaterol (ONBREZ® 150 MCG) Versus Tiotropium (SPIRIVA®) in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) IN TURKEY

    Nov 1, 2014, 00:00

  • Treatment Strategies For Stage Ib Cervical Cancer- A Cost-Effectiveness Analysis

    Nov 1, 2014, 00:00

  • Top 20 Orphan Drugs Availability, Pricing and Reimbursement In Slovakia- 2005-2012 Review

    Nov 1, 2014, 00:00

  • Costs Of Treating Cardiovascular Events In Germany- A Systematic Literature Review

    Nov 1, 2014, 00:00

  • Opioid Prescribing and the Impact of Branded Generics

    Nov 1, 2014, 00:00

  • Is the rule of halves applicable in Diabetes Type 2? Evidence from Greece

    Nov 1, 2014, 00:00

  • Modelling Long-Term Changes In Opioid Induced Constipation (OIC)

    Nov 1, 2014, 00:00

  • Effective Prioritisation of National Health Technology Assessments

    Nov 1, 2014, 00:00

  • The Relevance of Health Services Research for the Pharmaceutical Industry in Germany –Results of A Representative Online Survey

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Model of Dual-Mobility Cups for Total Hip Replacement in France

    Nov 1, 2014, 00:00

  • Evaluating Relationship Between White Blood Cells and Platelets During Recovery Phase In Dengue Hemorrhagic Fever Cases In Punjab, Pakistan- A Retrospective Study

    Nov 1, 2014, 00:00

  • Spontaneous Reporting of Adverse Drug Reactions in Geriatric Patients in India

    Nov 1, 2014, 00:00

  • Economic Evaluation of Omalizumab Compared With Standard Therapy in the Treatment of Severe Allergic Asthma in Adult Patients in Gree a Cost Effectiveness Analysis Based on Clinical Trial and Real-World Data

    Nov 1, 2014, 00:00

  • A Comparison of the Impact of Rheumatic Diseases and Other Chronic Diseases on Early Retirement in Portugal

    Nov 1, 2014, 00:00

  • Outpatient Treatment of Adolescents with Antidepressants in Japan

    Nov 1, 2014, 00:00

  • Study Of Costs Of The Cardiac And Diabetes Mellitus Patient In A Cardiology Hospital Of High Complexity

    Nov 1, 2014, 00:00

  • Discrepancy Between National Drug Recommendations And Local Uptake in the Swedish Inpatient Sector

    Nov 1, 2014, 00:00

  • Pharmacoeconomics and its Applications – Emerging Role in India

    Nov 1, 2014, 00:00

  • Hipos-ER (Hypoglycemia in Portugal Observational Study – Emergency Room)- Outcomes with Different Anti-Hyperglycemic Agents

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis (Cua) of First-Line Actinic Keratosis (Ak) Treatments in Finland

    Nov 1, 2014, 00:00

  • Transitional Clinic Utilization and General Well Being of Ugandan Young Adults Living with HIV/AIDS

    Nov 1, 2014, 00:00

  • A Comaprative Cross-Sectional Study On Health-Related Quality Of Life In Psoriasis From Hungary And Iran

    Nov 1, 2014, 00:00

  • A Prospective Pharmacoeconomic Study of Bilateral Prostaglandin/ Prostamide Therapy for Lowering Intraocular Pressure (Iop) in the Patients in South India

    Nov 1, 2014, 00:00

  • Cost and Duration Of Regulatory Process in an Observational Study in Europe and USA

    Nov 1, 2014, 00:00

  • Variations In Treatment Patterns and Disease Severity Among Patients With Psoriasis Receiving Their First Biologic Therapy In Europe (Eu)

    Nov 1, 2014, 00:00

  • Application of Threshold Value for Cost-Effectiveness in Recommendations Issued by Agency for Health Technology Assessment in Poland for Cancer Drug Technologies

    Nov 1, 2014, 00:00

  • A Cost-Effectiveness Evaluation for a New Therapy in HIV Treatment

    Nov 1, 2014, 00:00

  • French Utility Elicitation in Previously Treated European Patients with Indolent Non-Hodgkin Lymphoma (INHL)

    Nov 1, 2014, 00:00

  • Economic Impact of Combining Metformin with Dipeptidyl Peptidase Inhibitors In Diabetic Patients With Renal Failure

    Nov 1, 2014, 00:00

  • Valuing EQ-5D-5L- Does the Ordering of the Health Dimensions Impact on Health State Valuations?

    Nov 1, 2014, 00:00

  • Provincial Entry of New Drugs In China

    Nov 1, 2014, 00:00

  • Development of a Survey to Quantify Parents' Priorities for Vaccinating Children Against Rotavirus

    Nov 1, 2014, 00:00

  • What Really Matters? A Multi-View Perspective of One Patient's Hospital Experience

    Nov 1, 2014, 00:00

  • A Comparison of Patient-Reported and Laboratory Outcomes Between Hemodialysis and Peritoneal Dialysis Patients in a Multi-Ethnic Asian Population

    Nov 1, 2014, 00:00

  • An Evaluation of Medical Resource Utilisation In Patients With Autosomal Dominant Polycystic Kidney Disease In Europe

    Nov 1, 2014, 00:00

  • An Economic Model to Compare the Different Empiric and First/Second Line Treatment Regimens for Suspected Methicillin-Resistant Staphylococcus Aureus Nosocomial Pneumonia

    Nov 1, 2014, 00:00

  • Use Patterns and Costs of Isolated Limb Perfusion and Infusion in the Treatment of Regionally Metastatic Melanoma- A Retrospective Database Analysis

    Nov 1, 2014, 00:00

  • Assessing Assessment- Does Health Technology Assessment Do Its Job of Controlling Costs Without Compromising Quality?

    Nov 1, 2014, 00:00

  • Optimizing Process Efficiency Through Implanting Reveal Linq Verse Reveal Xt/Dx From Three Spanish Hospital Perspective

    Nov 1, 2014, 00:00

  • Health Care Utilizations And Costs Of Insulin Patient-Driven Titration Versus Physician-Driven Titration- Evidence Based On A Clinical Trial Of Biphasic Insulin Aspart 30 Twice Daily In People With Type 2 Diabetes In China

    Nov 1, 2014, 00:00

  • Cost-Minimization Analysis of Methadona Opioid Analgesic for Mexican Patients With Acute and Chronic Secondary Cancer As Rotation Option In Severe Pain

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of the New Biomarkers for Diagnosis of Acute Kidney Injury in Children After Cardiac Surgery

    Nov 1, 2014, 00:00

  • Diagnosis And Management Of Moderate-To-Severe Irritable Bowel Syndrome With Constipation (Ibs-C) In Spain- The Ibis-C Study

    Nov 1, 2014, 00:00

  • Breast Cancer Awareness Survey

    Nov 1, 2014, 00:00

  • Health-Related Quality of Life In Patients With Cervical Cancer in Indonesia

    Nov 1, 2014, 00:00

  • Heal Rate In 4,190 Fresh Fractures Treated With Low-Intensity Pulsed Ultrasound (Lipus)

    Nov 1, 2014, 00:00

  • Burden of Disease in Stage IV Non-Small Cell Lung Cancer- Comparing ALK Positive and ALK Negative Mutation Status in Egypt, Russia and the United Arab Emirates

    Nov 1, 2014, 00:00

  • The Prevalence and Disease Burden of Treatment-Resistant Depression - a Systematic Review of the Literature

    Nov 1, 2014, 00:00

  • Costs of Absenteeism In Psoriatic and Enteropathic Arthropathies Based On Real-Life Data From Poland's Social Insurance Institution Database In 2012

    Nov 1, 2014, 00:00

  • The Impact of Economic Crisis on Suicide Rates in Greece

    Nov 1, 2014, 00:00

  • Cost Effectiveness Analysis Of Mitraclip In Mitral Regurgitation For High Risk Patients

    Nov 1, 2014, 00:00

  • Impact of Health Care Reform on Drug Reimbursement Decision-Making In Taiwan

    Nov 1, 2014, 00:00

  • Sustainable Measurement of Response Shift in Prostate Cancer Patients- Adjusting Health Related Quality of Life with the Then-Test

    Nov 1, 2014, 00:00

  • The Impact of Long-Term Clinical Evidence on Cost-Effectiveness of Exenatide Once Weekly (Bydureon®) Versus Insulin Glargine for Patients With Type 2 Diabetes Mellitus (T2dm) From A Uk Nhs Perspective

    Nov 1, 2014, 00:00

  • A Qualitative Assessment of Doctors Perception Towards the Quality of Pharmaceutical Care Services in Khyber Pakhtunkhwa, Pakistan

    Nov 1, 2014, 00:00

  • Cost Effective Analysis of Dry Powdered Inhalers Versus Metered Dose Inhalers of Salbutamol for Asthma in Rural Secondary Care Hospital of South India

    Nov 1, 2014, 00:00

  • Prioritization of Future Outcomes Research Studies in Chronic Myeloid Leukemia- Value of Information Analysis

    Nov 1, 2014, 00:00

  • Retrospective Public Health Impact of a Quadrivalent Influenza Vaccine in the United States Over the Period 2000-2014

    Nov 1, 2014, 00:00

  • Misuse, Abuse, and Diversion of instanyl® (Fentanyl Nasal Spray) in France

    Nov 1, 2014, 00:00

  • Pediatrician's Perspective On Pneumococcal Conjugate Vaccines In India- An Exploratory Study

    Nov 1, 2014, 00:00

  • Modeling The Impact Of A Digital Health Feedback System In Uncontrolled Hypertensive Patients

    Nov 1, 2014, 00:00

  • Comparative Pharmacoeconomics Studies of Treatment for Major Depressive Disorder in China

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Amfepramone (Diethylpropion) for the Obesity Treatment In Mexico

    Nov 1, 2014, 00:00

  • Modelling Dependence Between Disability Status and Health Service Costs of People With Rheumatoid Arthritis in Hungary

    Nov 1, 2014, 00:00

  • Application Of A Model Of Decision Based On Fuzzy Logic To Pharmacoeconomics- Ranibizumab Verse Aflibercert In AMD

    Nov 1, 2014, 00:00

  • An Overview of the Biosimilar Market in the Us

    Nov 1, 2014, 00:00

  • Indirect Costs Among Patients with Hepatitis C Virus

    Nov 1, 2014, 00:00

  • Confirmation of the Factor Structure of the Proqol-HIV Questionnaire to Assess Health-Related Quality of Life in PLWHA

    Nov 1, 2014, 00:00

  • Evaluation of Potential Waste Of Growth Hormone Across Available Growth Hormone Pen Devices And An Electronic Growth Hormone Delivery Device

    Nov 1, 2014, 00:00

  • Impact on Hospitalization Derived from the Use of Denosumab for the Prevention of Skeletal-Related Events in Patients with Bone Metastases Secondary to Breast Cancer in Germany

    Nov 1, 2014, 00:00

  • How Much the Appropriate Tobacco Price Would Be?- A Discrete Choice Experiment of General Public in Japan

    Nov 1, 2014, 00:00

  • Patient Access To Life-Saving Medication; Preventing Stock-Outs Due To Parallel Trade

    Nov 1, 2014, 00:00

  • Risk Sharing Agreement Considerations for Pharmaceuticals in China Makret

    Nov 1, 2014, 00:00

  • Patterns of Use of Tests to Monitor Disease Activity Among Patients With Relapsing Remitting Multiple Sclerosis in the United States and Europe

    Nov 1, 2014, 00:00

  • Economic Burden of Hospitalized Pneumonia from a Private Health Care System Perspective in Brazil

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Comparison Of Botulinum Toxin Type A Plus Best Supportive Care Versus Best Supportive Care Alone In The Treatment Of Idiopathic Overactive Bladder With Urinary Incontinence Among Patients Not Adequately Managed By Anticho ...

    Nov 1, 2014, 00:00

  • MODELLING HEALTH-RELATED QUALITY OF LIFE (HRQOL) LONGITUDINALLY. A BAYESIAN MIXED BETA REGRESSION APPROACH

    Nov 1, 2014, 00:00

  • Proposal for a Comprehensive Definition of Budget Impact Analysis

    Nov 1, 2014, 00:00

  • What Is Working Well In Louisiana For Us Employers- A Descriptive Analysis of Employers Actively Engaged In Promoting Employee Health

    Nov 1, 2014, 00:00

  • Cost-Effectiveness and Value of Information Analyses of Nutritional Support in Preventing Pressure Ulcers in High Risk Hospitalised Patients

    Nov 1, 2014, 00:00

  • Drug Therapy Problems in Patients on Antihypertensives with Antidiabetic Drugs in Two Tertiary Health Institutions in Niger Delta Region, Nigeria

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Research and Application In 10 Asian Countries Between 2003 and 2013- A Systematic Review

    Nov 1, 2014, 00:00

  • Treatment and Monitoring of Venous Thromboembolism (VTE) Among Hospitalized Patients in China

    Nov 1, 2014, 00:00

  • Setting up the Right Scenarios for Cost-Effectiveness Analysis- An Example with Anticoagulants for Stroke Prevention in Atrial Fibrillation Patients in China

    Nov 1, 2014, 00:00

  • Re-Validation of the Self-Injection Assessment Questionnaire© (Siaqv2.0©) in Rheumatoid Arthritis Patients on Certolizumab Pegol Treatment

    Nov 1, 2014, 00:00

  • What are the Lifelong costs of Vaccinating one Individual? The French Case

    Nov 1, 2014, 00:00

  • Impact of Health Policy Changes on Trends of Pharmaceutical Market in Turkey

    Nov 1, 2014, 00:00

  • Price Comparison Between the Essential and Non-Essential Anti-Infective Medicines Among National Reimbursement Drug List in China

    Nov 1, 2014, 00:00

  • Real World Data in Oncology- Third- and Fourth-Line Treatments Administered in Metastatic Colon-Rectal Cancer (MCRC)

    Nov 1, 2014, 00:00

  • Sofosbuvir For The Treatment Of Chronic Hepatitis C- A Comprehensive Cost-Effectiveness Analysis Across Hcv Genotypes, Pretreatment Conditions And Hiv Co-Infection

    Nov 1, 2014, 00:00

  • Mcda Approach To Ranking Rare Diseases In Russia- Preliminary Results

    Nov 1, 2014, 00:00

  • A Comparison of International Health Technology Assessment Systems – Does The Perfect System Exist?

    Nov 1, 2014, 00:00

  • Prevalence and Treatment of Chronic Lymphocytic Leukaemia (Cll) In Germany- An Analysis of Sickness Funds

    Nov 1, 2014, 00:00

  • Impact Of A Pharmacological Cardioversion With Vernakalant On The Management Cost Of Recent Atrial Fibrillation In Belgium

    Nov 1, 2014, 00:00

  • Analysis of ‘Revolving Door' Patients in Opioid Dependent Patients- the Impact of Treatment Discontinuation on Relapse Rates and Health Care Costs in us Public Health Insurance Claims

    Nov 1, 2014, 00:00

  • Comparative Efficacy and Safety of Empagliflozin with Other Antidiabetic Drugs for the Third Line Treatment of Type 2 Diabetes Mellitus

    Nov 1, 2014, 00:00

  • A Web Based Optimisation Model For A Portfolio Of Preventative Interventions Utilizing Multi Criteria Decision Analyses (Mcda) Framework

    Nov 1, 2014, 00:00

  • Social Contacts Reduce Negative Symptoms, Especially Emotional Withdrawal in Patients with Schizophrenia

    Nov 1, 2014, 00:00

  • Economic Burden of Asthma in Vietnam- An Analysis from Patients' Perspective

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Ugt1a1 Genotyping Before Colorectal Cancer Treatment with Irinotecan

    Nov 1, 2014, 00:00

  • Impact of Apremilast on Physical Function over 52 weeks in Patients with Active Psoriatic Arthritis

    Nov 1, 2014, 00:00

  • Logistics of Monitoring of Vitamin K Antagonists in Western European Countries- Prefer in Vte Registry

    Nov 1, 2014, 00:00

  • Factors Influencing Job Satisfaction Among Nurses of Pafos General Hospital in Cyprus

    Nov 1, 2014, 00:00

  • How Iranian People Think About Generic Substitution?

    Nov 1, 2014, 00:00

  • Analysis of Cardiac Implants Recalls in the Last Decade- An International Comparison

    Nov 1, 2014, 00:00

  • Medicare Provider Utilization and Payment Data- The Book to Bill Gap

    Nov 1, 2014, 00:00

  • Getting To Reimbursement Faster- Combining Randomised, Pragmatic, and Observational Clinical Trial Data

    Nov 1, 2014, 00:00

  • Is G-Ba Strategically Discounting The Benefit Assessment of Relatively High Cost Drugs?

    Nov 1, 2014, 00:00

  • Identifying Psoriasis and Psoriatic Arthritis Patients in Retrospective Databases When Diagnosis Code Is Not Available- A Validation Study Comparing Medication/Prescriber Visit Based Algorithms To Diagnosis Codes

    Nov 1, 2014, 00:00

  • Epidemiology of Patients with Metastatic Castrate Resistant Prostate Cancer in Europe and Australia

    Nov 1, 2014, 00:00

  • The Efficacy and Effectiveness in HBA1C-Lowering is Dependent on Baseline Body Mass Index (BMI) for Sitagliptin but not Canagliflozin in the Treatment of Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2014, 00:00

  • Examination of the Burden of Illness of U. S. Medicare Patients Diagnosed with Chronic Obstructive Pulmonary Disease

    Nov 1, 2014, 00:00

  • Evaluating Working Ability and Quality of Life of Patients with Multiple Sclerosis

    Nov 1, 2014, 00:00

  • Burden of Disease Caused by Influenza in Germany - A Retrospective Claims Database Analysis

    Nov 1, 2014, 00:00

  • The Effect of Insomnia and Insomnia Treatment Side Effects on Health Status, Work Productivity, and Health Care Resource Use

    Nov 1, 2014, 00:00

  • Budgetary Impact Analysis Of Reimbursement Varenicline In The Smoking Cessation Treatment Of Patients With Cardiovascular Diseases, Chronic Obstructive Pulmonary Disease Or Type-2 Diabetes Mellitus- A National Health System Perspective In S ...

    Nov 1, 2014, 00:00

  • Usage of Self-Monitoring of Blood Glucose (Smbg) By Diabetes Therapy Type in India

    Nov 1, 2014, 00:00

  • Hipos-ER (Hypoglycemia in Portugal Observational Study – Emergency Room)- Clinical Outcomes in Admitted Patients

    Nov 1, 2014, 00:00

  • Impact of Acute Bleeding on Daily Activities of Patients with Congenital Hemophilia with Inhibitors and Their Caregivers and Families- Observations from the Dosing Observational Study in Hemophilia (DOSE)

    Sep 1, 2014, 00:00

  • A Patient-Level Calibration Framework for Evaluating Surveillance Strategies- A Case Study of Mammographic Follow-Up After Early Breast Cancer

    Sep 1, 2014, 00:00

  • Table of Contents

    Sep 1, 2014, 00:00

  • Copyright/Subscription

    Sep 1, 2014, 00:00

  • Transitions between Care Settings in Dementia- Are They Relevant in Economic Terms?

    Sep 1, 2014, 00:00

  • Impact of Mental Health Comorbidities on Health Care Utilization and Expenditure in a Large US Managed Care Adult Population with ADHD

    Sep 1, 2014, 00:00

  • Instructions for Authors

    Sep 1, 2014, 00:00

  • Can Value-Based Insurance Impose Societal Costs?

    Sep 1, 2014, 00:00

  • Mapping between the Roland Morris Questionnaire and Generic Preference-Based Measures

    Sep 1, 2014, 00:00

  • It’s Good to Have a Choice; Now Let’s Get More Data- Response to Armstrong et al.’s “Response to Lai et al., Development of a Symptom Index for Patients with Primary Brain Tumors”

    Sep 1, 2014, 00:00

  • Analyzing Overall Survival in Randomized Controlled Trials with Crossover and Implications for Economic Evaluation

    Sep 1, 2014, 00:00

  • The Nocturia Impact Diary- A Self-Reported Impact Measure to Complement the Voiding Diary

    Sep 1, 2014, 00:00

  • Pharmaceutical Portfolio Management- Global Disease Burden and Corporate Performance Metrics

    Sep 1, 2014, 00:00

  • Validation of the IMS CORE Diabetes Model

    Sep 1, 2014, 00:00

  • Editorial Board

    Sep 1, 2014, 00:00

  • Response to Lai et al., “Development of a Symptom Index for Patients with Primary Brain Tumors”

    Sep 1, 2014, 00:00

  • Cancer Chemotherapy Treatment Patterns and Febrile Neutropenia in the US Veterans Health Administration

    Sep 1, 2014, 00:00

  • Dynamic Medication Adherence Modeling in Primary Prevention of Cardiovascular Disease- A Markov Microsimulation Methods Application

    Sep 1, 2014, 00:00

  • Table of Contents

    Jul 1, 2014, 00:00

  • NICE’s Selective Application of Differential Discounting- Ambiguous, Inconsistent, and Unjustified

    Jul 1, 2014, 00:00

  • Copyright/Subscription

    Jul 1, 2014, 00:00

  • A Framework to Evaluate the Cost-Effectiveness of the NADiA ProsVue Slope to Guide Adjuvant Radiotherapy among Men with High-Risk Characteristics Following Prostatectomy for Prostate Cancer

    Jul 1, 2014, 00:00

  • PRO Data Collection in Clinical Trials Using Mixed Modes- Report of the ISPOR PRO Mixed Modes Good Research Practices Task Force

    Jul 1, 2014, 00:00

  • Chinese Time Trade-Off Values for EQ-5D Health States

    Jul 1, 2014, 00:00

  • Comparison of Contemporaneous EQ-5D and SF-6D Responses Using Scoring Algorithms Derived from Similar Valuation Exercises

    Jul 1, 2014, 00:00

  • An Updated Method for Risk Adjustment in Outcomes Research

    Jul 1, 2014, 00:00

  • Time Is Money, But How Much? The Monetary Value of Response Time for Thai Ambulance Emergency Services

    Jul 1, 2014, 00:00

  • Cognitive Overload? An Exploration of the Potential Impact of Cognitive Functioning in Discrete Choice Experiments with Older People in Health Care

    Jul 1, 2014, 00:00

  • Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease- Cross-Model Comparison of Hypothetical Treatment Scenarios

    Jul 1, 2014, 00:00

  • Two Approaches to Incorporate Clinical Data Uncertainty into Multiple Criteria Decision Analysis for Benefit-Risk Assessment of Medicinal Products

    Jul 1, 2014, 00:00

  • Improving the Contribution of Regulatory Assessment Reports to Health Technology Assessments—A Collaboration between the European Medicines Agency and the European network for Health Technology Assessment

    Jul 1, 2014, 00:00

  • Review of the Task Force Report on PRO Data Collection in Clinical Trials Using Mixed Modes

    Jul 1, 2014, 00:00

  • Should I Stay or Should I Go Home? A Latent Class Analysis of a Discrete Choice Experiment on Hospital-At-Home

    Jul 1, 2014, 00:00

  • Treating to Target with Etanercept in Rheumatoid Arthritis- Cost-Effectiveness of Dose Reductions When Remission Is Achieved

    Jul 1, 2014, 00:00

  • A Comparison of National Guidelines for Network Meta-Analysis

    Jul 1, 2014, 00:00

  • Editorial Board

    Jul 1, 2014, 00:00

  • An Economic Evaluation of Salt Reduction Policies to Reduce Coronary Heart Disease in England- A Policy Modeling Study

    Jul 1, 2014, 00:00

  • A Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy and Automated Insulin Suspension versus Standard Pump Therapy for Hypoglycemic Unaware Patients with Type 1 Diabetes

    Jul 1, 2014, 00:00

  • Instructions for Authors

    Jul 1, 2014, 00:00

  • The Role of Economic Evaluation in Meeting IOM’s Recommendations on Delivering High-Quality Cancer Care

    Jul 1, 2014, 00:00

  • The Effect of Presenting Information about Invasive Follow-Up Testing on Individuals’ Noninvasive Colorectal Cancer Screening Participation Decision- Results from a Discrete Choice Experiment

    Jul 1, 2014, 00:00

  • The Effects of Total Knee Arthroplasty on Physical Functioning and Health among the Under Age 65 Population

    Jul 1, 2014, 00:00

  • Physician Social Networks and Variation in Rates of Complications After Radical Prostatectomy

    Jul 1, 2014, 00:00

  • In the paper “A Questionnaire to Assess the Relevance and Credibility of Observational Studies to Inform Health Care Decision Making- An ISPOR-AMCP-NPC Good Practice Task Force Report” published in Value in Health, Volume 17 (March/April 20 ...

    Jun 1, 2014, 00:00

  • A Review of FDA Warning Letters and Notices of Violation Issued for Patient-Reported Outcomes Promotional Claims between 2006 and 2012

    Jun 1, 2014, 00:00

  • Review of Utility Values for Economic Modeling in Type 2 Diabetes

    Jun 1, 2014, 00:00

  • Patient-Centeredness in the Design of Clinical Trials

    Jun 1, 2014, 00:00

  • Cost-Effectiveness of a Computerized Provider Order Entry System in Improving Medication Safety Ambulatory Care

    Jun 1, 2014, 00:00

  • Estimation of Potential Gain in Quality of Life from Early Detection of Cervical Cancer

    Jun 1, 2014, 00:00

  • Is the UK NICE “Reference Case” Influencing the Practice of Pediatric Quality-Adjusted Life-Year Measurement within Economic Evaluations?

    Jun 1, 2014, 00:00

  • Instructions for Authors

    Jun 1, 2014, 00:00

  • Comparative Cost Analysis of Clinical Reminder for HIV Testing at the Veterans Affairs Healthcare System

    Jun 1, 2014, 00:00

  • Multicriteria Decision Analysis in the Reimbursement of New Medical Technologies- Real-World Experiences from Hungary

    Jun 1, 2014, 00:00

  • Long-Term Air Humidification Therapy Is Cost-Effective for Patients with Moderate or Severe Chronic Obstructive Pulmonary Disease or Bronchiectasis

    Jun 1, 2014, 00:00

  • Bazedoxifene versus Oral Bisphosphonates for the Prevention of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis at Higher Risk of Fracture- A Network Meta-Analysis

    Jun 1, 2014, 00:00

  • Discrete Choice Experiment to Estimate Breast Cancer Patients’ Preferences and Willingness to Pay for Prophylactic Granulocyte Colony-Stimulating Factors

    Jun 1, 2014, 00:00

  • A Retrospective, Observational Study of Patient Outcomes for Critically Ill Patients Receiving Parenteral Nutrition

    Jun 1, 2014, 00:00

  • Sharing Risk between Payer and Provider by Leasing Health Technologies- An Affordable and Effective Reimbursement Strategy for Innovative Technologies?

    Jun 1, 2014, 00:00

  • A Study of the Relationship between Health and Subjective Well-Being in Parkinson’s Disease Patients

    Jun 1, 2014, 00:00

  • Searching for Indirect Evidence and Extending the Network of Studies for Network Meta-Analysis- Case Study in Venous Thromboembolic Events Prevention Following Elective Total Knee Replacement Surgery

    Jun 1, 2014, 00:00

  • Copyright/Subscription

    Jun 1, 2014, 00:00

  • A Program of Methodological Research to Arrive at the New International EQ-5D-5L Valuation Protocol

    Jun 1, 2014, 00:00

  • A Comparison of Hong Kong and United Kingdom SF-6D Health States Valuations Using a Nonparametric Bayesian Method

    Jun 1, 2014, 00:00

  • Cost-Effectiveness of Second-Generation Antipsychotics for the Treatment of Schizophrenia

    Jun 1, 2014, 00:00

  • Development of a Scale to Assess Performance Following Primary Total Knee Arthroplasty

    Jun 1, 2014, 00:00

  • Modeling a Preference-Based Index for Two Condition-Specific Measures (Asthma and Overactive Bladder) Using a Nonparametric Bayesian Method

    Jun 1, 2014, 00:00

  • Editorial Board

    Jun 1, 2014, 00:00

  • Construct Validity of the Swedish Version of the Revised Piper Fatigue Scale in an Oncology Sample—A Rasch Analysis

    Jun 1, 2014, 00:00

  • Table of Contents

    Jun 1, 2014, 00:00

  • Patient Preferences for Treatment of Low Back Pain—A Discrete Choice Experiment

    Jun 1, 2014, 00:00

  • The Impact of Differences between Patient and General Population EQ-5D-3L Values on the Mean Tariff Scores of Different Patient Groups

    Jun 1, 2014, 00:00

  • Questioning Patient Subgroups for Benefit Assessment- Challenging the German Gemeinsamer Bundesausschuss Approach

    Jun 1, 2014, 00:00

  • Medical Device Reimbursement Coverage and Pricing Rules in Korea- Current Practice and Issues with Access to Innovation

    Jun 1, 2014, 00:00

  • what happens when personalized medicine guidelines don’t agree? A systematic review of clinical guidelines for thiopurine methyltransferase testing for dose selection of thiopurines

    May 1, 2014, 00:00

  • The Affordable Care Act And Pharmacy Benefit Managers- Health Care Exchanges And Projected Outcomes

    May 1, 2014, 00:00

  • Shortages Of Drugs With Approved Orphan Indications In The United States

    May 1, 2014, 00:00

  • Health Care Utilization And Costs Among Privately Insured Children With Orofacial Clefts

    May 1, 2014, 00:00

  • Opportunities For The Future Of United States Medical Device Surveillan An Analysis Of The Joint Replacement Registry (Jrr) Landscape In The United States

    May 1, 2014, 00:00

  • Estimating Long-Term Functional Impairments Of Rheumatoid Arthritis- Integration Of Nationwide Survival With Health Assessment From Clinical Cohort

    May 1, 2014, 00:00

  • Dealing with competing risks in diabetes mellitus- Comparison of results using a markov versus a Micro-Markov simulation model

    May 1, 2014, 00:00

  • Utilization, Costs And Reimbursement Of Inpatient Treatment Of Acute Bacterial Skin And Skin Structure Infections Among The Medicare Fee-For-Service Population

    May 1, 2014, 00:00

  • Evidence Based Approach To Evaluate And Improve Access To Medicines In Emerging Markets

    May 1, 2014, 00:00

  • Validation Of The United States Huntington’s Disease Quality Of Life Battery For Carers

    May 1, 2014, 00:00

  • The Association Between Continuity Of Care And Potentially Inappropriate Concomitant Medication In Continuous Non-Steroidal Anti-Inflammatory Drug Users

    May 1, 2014, 00:00

  • Cost Consequence Analysis Of Apixaban Versus Warfarin In Patients With Atrial Fibrillation In The Mexican Public Health Sector

    May 1, 2014, 00:00

  • Association Between Cardiovascular Drugs and Colon Cancer

    May 1, 2014, 00:00

  • Length Of Stay And Mortality In Hyperphosphatemia Patients Administered Phosphate Binders Compared With Matched Controls

    May 1, 2014, 00:00

  • An Outcomes Model for High-Risk Non-Muscle-Invasive Bladder Cancer Treatment Options

    May 1, 2014, 00:00

  • Increased In Acute Health Care Use Among People Living With Human Immunodeficiency Virus (Hiv) And Co-Morbid Depression In Ontario- A Longitudinal Study

    May 1, 2014, 00:00

  • Risk heterogeneity in clinical trials- An evaluation of 25 large clinical trials using individual patient data

    May 1, 2014, 00:00

  • Eq-5d- Which Dimension Matters Most Among Diabetes Patients

    May 1, 2014, 00:00

  • Validation of the telephone-administered of the age and stage questionnaire and the revised-prescreening denver questionnaire- Results from the otis antidepressants in pregnancy study

    May 1, 2014, 00:00

  • Real-World Utilization Of Certolizumab Pegol (Czp) For The Treatment Of Rheumatoid Arthritis (Ra) In The United Kingdom

    May 1, 2014, 00:00

  • The Association of Chemotherapy Versus Hormonal Therapy and Health Outcomes Among Patients with Hormone Receptor-Positive, Her2-Negative Metastatic Breast Cancer- Experience From the Patient Perspective

    May 1, 2014, 00:00

  • Change in employment and work performance among caregivers

    May 1, 2014, 00:00

  • Treatment Of Neuropathic Pain With The Capsaicin 8% Patch Qutenzatm- Evaluation Of Time To Retreatment, Patch Usage And Pain Alleviation

    May 1, 2014, 00:00

  • Evaluation Of Association Between Diabetes Related Quality Measure Achievement And Diabetes Complications In A Medicare Advantage Population

    May 1, 2014, 00:00

  • Evaluation Analysis Comparing Tiotropium With Salmeterol Or Ipratropium In Chronic Obstructive Pulmonary Disease In Taiwan

    May 1, 2014, 00:00

  • Health Related Quality of Life in Patients with Metastatic, Relapsed, or Inoperable Squamous Cell Carcinoma of the Head and Neck in India

    May 1, 2014, 00:00

  • Economic Evaluation- A Challenge In Incorporating New Health Technologies To The Brazilian Public Health System (SUS)

    May 1, 2014, 00:00

  • Framingham risk score estimates higher CVD risk than UKPDS risk engine in newly diagnosed type 2 diabetes mellitus patients in North India

    May 1, 2014, 00:00

  • Delayed Treatment Modifications For Patients With Type 2 Diabetes Mellitus (T2dm) With Very Poor Glycemic Control

    May 1, 2014, 00:00

  • Risk on using logistic regression to illustrate exposure-response relationship of infectious disease

    May 1, 2014, 00:00

  • A Randomized Clinical Study to Evaluate Effects of Eicosapentaenoic Acid Enriched Oral Nutritional Supplement Along with Radio-Chemotherapy in Patients with Colorectal Carcinoma- A Cost-Effectiveness Analysis

    May 1, 2014, 00:00

  • Value Of A Zero-Copay Drug Program- Implication For Employee Wellness Programs

    May 1, 2014, 00:00

  • The Impact Of Medical Device Use On Hospital Costs

    May 1, 2014, 00:00

  • Portrayal Of Stereotypes In Direct To Consumer Advertising Of Anti-Psychotics And Statins

    May 1, 2014, 00:00

  • The State Of The Comparative Effectiveness Research (Cer) Environment- Surveys Of Stakeholders And Influentials

    May 1, 2014, 00:00

  • Survival crossover adjustment and cost effectiveness analysis- An empirical and methodological review with application

    May 1, 2014, 00:00

  • Progress In Personalized Medicine Is Slower Than Some Had Expected, Partly Because Of The Science And Partly Because Of Insufficient Economic Incentives, Particularly For Investing In Molecular Diagnostics (MDX)

    May 1, 2014, 00:00

  • Social network analysis of prescription patterns

    May 1, 2014, 00:00

  • Financial Impact Of Using An Innovative Device Algorithm To Automatically Optimize Biventricular Pacing Devices In Japan

    May 1, 2014, 00:00

  • Blood Pressure Testing At Community Pharmacies Promote Better Hypertension Management

    May 1, 2014, 00:00

  • A Retrospective, Cross Sectional Study On The Real-World Values Of Cardiovascular Risk Factors Using A Health Care Database In Japan

    May 1, 2014, 00:00

  • A Novel Colorectal Cancer Model with Sessile Serrated Adenoma Pathway to Evaluate the Cost-Effectiveness of Various Screening Strategies

    May 1, 2014, 00:00

  • Nature Of Endpoints In Market Access Agreements

    May 1, 2014, 00:00

  • Estimation Of Change In Prescription Drug Expenditures On The Reference Pricing System In South Korea

    May 1, 2014, 00:00

  • Adherence barriers to ace-is and arbs among non-adherent hypertensive patients with diabetes enrolled in a medicare advantage plan

    May 1, 2014, 00:00

  • Incidence of antipsychotic polypharmacy in the texas medicaid population

    May 1, 2014, 00:00

  • Saxagliptin/metformin extended-release (XR) for the type 2 diabetes (T2DM) treatment in venezuela- A budget impact analysis

    May 1, 2014, 00:00

  • A Mixed Treatment Comparison (Mtc) To Compare The Efficacy Of Botulinum Toxin Type A Treatments For Cervical Dystonia

    May 1, 2014, 00:00

  • Long-Acting Muscarinic Antagonists (Lama) In Chronic Obstructive Pulmonary Disease (Copd)- A Rare Events Meta Analysis Of Clinically Relevant Adverse Events

    May 1, 2014, 00:00

  • The Epidemiology Of Gaucher DiseaseA Comprehensive Review Of The Literature

    May 1, 2014, 00:00

  • Treatment Patterns Of Care For Non-Valvular Atrial Fibrilation Patients At A National Institute Of Care In Peru

    May 1, 2014, 00:00

  • Health Care Cost and Utilization Among Patients Treated with Stivarga

    May 1, 2014, 00:00

  • Improved bootstrap point and confidence interval estimation of the incremental cost-effectiveness ratio (ICER)

    May 1, 2014, 00:00

  • Comparison of the doubly robust estimation method to the propensity score method in a diabetes-related comparative health economics study

    May 1, 2014, 00:00

  • Assessing The Quality Of Health Economic Evaluations Attached To Price Applications For New Pharmaceuticals Proposed For Inclusion In The Finnish Reimbursement System

    May 1, 2014, 00:00

  • Conceputalizing A Model To Assess The Impact Of International Reference Pricing Reforms

    May 1, 2014, 00:00

  • Cost-Utility Analysis Of Angiotensin-Converting Enzyme Inhibitor-Based Treatment Compared To Thiazide Diuretic-Based Treatment In An Elderly Hypertensive Population Considering Major Comorbidities At The Community Level

    May 1, 2014, 00:00

  • Mediation analysis of effect of lurasidone on patient functioning in bipolar depression- Direct effects and indirect effects mediated through improvement in depression symptoms

    May 1, 2014, 00:00

  • Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes- Dose-response association with all-cause mortality, cardiovascular events, and incident cancer

    May 1, 2014, 00:00

  • From private sites to big data without compromising privacy- A case of neuroimaging data classification

    May 1, 2014, 00:00

  • Triptan Use For Migraine Headache Among Adults With Cardiovascular Risk

    May 1, 2014, 00:00

  • Signs, Symptoms, And Existing Patient Reported Outcome (PRO) Measures In Community-Acquired Bacterial Pneumonia (CABP)- A Comprehensive Literature Review

    May 1, 2014, 00:00

  • Multi-Criteria Decision Analysis In Oncology- An Overview

    May 1, 2014, 00:00

  • Automatic development of clinical prediction models with genetic programming- A case study in cardiovascular disease

    May 1, 2014, 00:00

  • Meta-Analysis Of Il-2 Receptor Antagonist (Il-2 Ra) As Induction Therapy In Pediatric Renal Transplantation

    May 1, 2014, 00:00

  • Evaluating Costs and Utilization of Prostate Cancer Patients with Bone Metastases in the Outpatient Hospital Setting

    May 1, 2014, 00:00
  • «
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99 (current)
  • 100
  • »